$4.75 7.7%
Price vs. AI Score (Last 150 days)
Data gathered: December 6

Data Bits

Data Bits Value / Change Benchmark
Job Posts 13 0%
Sentiment 42 23.5%
Webpage traffic 32,000 -14.4%
Employee Rating 60 0%
Google Trends -100%
Linkedin Employees 760 N/A
Patents 29 0%
4chan Mentions 0% N/A
Facebook Engagement 229 7.5%
Facebook followers 1,714 0%
Stocktwits Mentions 1 0%
Stocktwits Subscribers 4,193 0%
Twitter Followers 4,759 0%
Instagram Followers 1,206 -0.1%
News Mentions 0%
Reddit Mentions 0%
Business outlook 28 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Adaptive Biotechnologies

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Adaptive Biotechnologies
Price $4.75
Target Price Sign up
Market Cap $644M
Dividend Yield 0
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2334M60M-26M-50M-51M
Q2 '2345M65M-19M-48M-47M
Q1 '2334M62M-28M-58M-57M
Q4 '2252M63M-12M-40M-39M
Q3 '2247M58M-10M-45M-45M

Insider Transactions

PISKEL KYLE filed to sell 87,305 shares at $4.1.
November 20 '23
SOOD NITIN filed to sell 214,808 shares at $6.5.
August 8 '23
PETERSON TYCHO filed to sell 399,219 shares at $8.1.
June 21 '23
PETERSON TYCHO filed to sell 399,219 shares at $8.5.
June 20 '23
PETERSON TYCHO filed to sell 454,891 shares at $7.2.
June 6 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.